AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

EDEN RESEARCH PLC

Board/Management Information Oct 24, 2022

7615_dirs_2022-10-24_d7cf3725-5cea-484e-ab0a-55260de19100.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8925D

Eden Research plc

24 October 2022

24 October 2022

Eden Research Plc

("Eden" or the "Company")

AIM Rule 17 Notification

Eden Research Plc (AIM: EDEN) the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, announces the following additional director disclosure provided pursuant to AIM Rule 17 and Schedule 2(g) of the AIM Rules.

Richard Horsman, Non-executive director of Eden, is Non-executive chairman of Toople Plc ("Toople"). On 21 October 2022, the Directors of Toople appointed an administrator to preserve value for creditors.

For further information contact:

Eden Research plc www.edenresearch.com
Sean Smith

Alex Abrey
01285 359 555
Cenkos Securities plc (Nominated advisor and broker)
Giles Balleny / Max Gould (corporate finance)

Michael Johnson (sales)
020 7397 8900
Hawthorn Advisors (Financial PR)
Victoria Ainsworth

Stephen Atkinson
[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RDNUSARRUUURUAA

Talk to a Data Expert

Have a question? We'll get back to you promptly.